Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-012307
Filing Date
2025-04-04
Accepted
2025-04-04 16:06:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20041152x2_defa14a.htm DEFA14A 19282
2 ny20041152x2_nc01.jpg GRAPHIC 406193
3 ny20041152x2_nc02.jpg GRAPHIC 295001
  Complete submission text file 0001140361-25-012307.txt   986541
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34949 | Film No.: 25814008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)